Autonomic Dysfunction in α-Synucleinopathies
- PMID: 31031694
- PMCID: PMC6474181
- DOI: 10.3389/fneur.2019.00363
Autonomic Dysfunction in α-Synucleinopathies
Abstract
The α-synucleinopathies are a group of neurodegenerative diseases characterized by abnormal accumulation of insoluble α-synuclein in neurons and glial cells, comprising Parkinson's disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy (MSA). Although varying in prevalence, symptom patterns, and severity among disorders, all α-synucleinopathies have in common autonomic nervous system dysfunctions, which reduce quality of life. Frequent symptoms among α-synucleinopathies include constipation, urinary and sexual dysfunction, and cardiovascular autonomic symptoms such as orthostatic hypotension, supine hypertension, and reduced heart rate variability. Symptoms due to autonomic dysfunction can appear before motor symptom onset, particularly in MSA and PD, hence, detection and quantitative analysis of these symptoms can enable early diagnosis and initiation of treatment, as well as identification of at-risk populations. While patients with PD, DLB, and MSA show both central and peripheral nervous system involvement of α-synuclein pathology, pure autonomic failure (PAF) is a condition characterized by generalized dysregulation of the autonomic nervous system with neuronal cytoplasmic α-synuclein inclusions in the peripheral autonomic small nerve fibers. Patients with PAF often present with orthostatic hypotension, reduced heart rate variability, anhydrosis, erectile dysfunction, and constipation, without motor or cognitive impairment. These patients also have an increased risk of developing an α-synucleinopathy with central involvement, such as PD, DLB, or MSA in later life, possibly indicating a pathophysiological disease continuum. Pathophysiological aspects, as well as developments in diagnosing and treating dysautonomic symptoms in patients with α-synucleinopathies are discussed in this review.
Keywords: Parkinson disease; autonomic dysfunction; dementia with Lewy bodies; dysautonomia; multiple system atrophy; pure autonomic failure; α-synucleinopathies.
Similar articles
-
The role of cardiovascular autonomic failure in the differential diagnosis of α-synucleinopathies.Neurol Sci. 2022 Jan;43(1):187-198. doi: 10.1007/s10072-021-05746-6. Epub 2021 Nov 24. Neurol Sci. 2022. PMID: 34817726 Free PMC article. Review.
-
An overview on pure autonomic failure.Rev Neurol (Paris). 2024 Jan-Feb;180(1-2):94-100. doi: 10.1016/j.neurol.2023.11.003. Epub 2023 Dec 20. Rev Neurol (Paris). 2024. PMID: 38129276 Review.
-
Different phenoconversion pathways in pure autonomic failure with versus without Lewy bodies.Clin Auton Res. 2021 Dec;31(6):677-684. doi: 10.1007/s10286-021-00829-y. Epub 2021 Oct 20. Clin Auton Res. 2021. PMID: 34669076 Free PMC article. Review.
-
Pure autonomic failure.Handb Clin Neurol. 2013;117:243-57. doi: 10.1016/B978-0-444-53491-0.00020-1. Handb Clin Neurol. 2013. PMID: 24095130 Review.
-
Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies.JAMA. 2024 Apr 16;331(15):1298-1306. doi: 10.1001/jama.2024.0792. JAMA. 2024. PMID: 38506839 Free PMC article.
Cited by
-
Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies.J Neurol. 2020 Dec;267(12):3444-3456. doi: 10.1007/s00415-020-09985-z. Epub 2020 Jun 27. J Neurol. 2020. PMID: 32594302 Free PMC article.
-
Clinical drug development for dementia with Lewy bodies: past and present.Expert Opin Investig Drugs. 2019 Nov;28(11):951-965. doi: 10.1080/13543784.2019.1681398. Epub 2019 Oct 28. Expert Opin Investig Drugs. 2019. PMID: 31614096 Free PMC article. Review.
-
Assessment of autonomic symptoms may assist with early identification of mild cognitive impairment with Lewy bodies.Int J Geriatr Psychiatry. 2022 Apr;37(4):10.1002/gps.5703. doi: 10.1002/gps.5703. Int J Geriatr Psychiatry. 2022. PMID: 35302677 Free PMC article.
-
It Is Time to Study Overlapping Molecular and Circuit Pathophysiologies in Alzheimer's and Lewy Body Disease Spectra.Front Syst Neurosci. 2021 Nov 18;15:777706. doi: 10.3389/fnsys.2021.777706. eCollection 2021. Front Syst Neurosci. 2021. PMID: 34867224 Free PMC article. Review.
-
6-hydroxydopamine and ovariectomy has no effect on heart rate variability parameters of females.Clinics (Sao Paulo). 2021 Oct 11;76:e3175. doi: 10.6061/clinics/2021/e3175. eCollection 2021. Clinics (Sao Paulo). 2021. PMID: 34644736 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources